Health
Explainer
How a 20-Year NIH Trial Proved Lifestyle Changes Outperform Metformin for Long-Term Health
4 sources · 71d ago
Explainer
The Evidence Pack: How CAR-T Cell Therapy is 'Resetting' the Immune System in Severe Autoimmune Diseases
5 sources · 71d ago
Acromegaly
FDA Approves Paltusotine as the First Once-Daily Oral Treatment for Acromegaly
6 sources · 72d ago
More in Health
ExplainerNature Therapy
The Evidence Pack: How 'Forest Bathing' Measurably Lowers Cortisol and Boosts Immune Function
Clinical Researchers 45%Public Health Advocates 35%Factlen Analysis 20%
4 sources · 72d ago
Deep DiveGenetic Medicine
The Evidence Pack: How the FDA-Approved Gene Therapy Otarmeni Restores Hearing in Genetic Deafness
Medical Researchers 40%Deaf Culture Advocates 30%Healthcare Payers 30%
4 sources · 72d ago
ExplainerDMD Cell Therapy
The Evidence Pack: How Deramiocel's Five-Year Data is Reshaping Duchenne Muscular Dystrophy Treatment
DMD Patients & Advocacy Groups 35%Pediatric Neurologists & Cardiologists 35%Biotech & Regulatory Analysts 30%
4 sources · 72d ago
Deep DiveLongevity Medicine
Major Human Trial Launches to Test Three FDA-Approved Drugs for Healthspan and New Regulatory Endpoint
Geroscience Researchers 40%Regulatory Pragmatists 35%Clinical Skeptics 25%
5 sources · 72d ago
Breast CancerExplainer
FDA Grants Full Approval to Datopotamab Deruxtecan for Metastatic Triple-Negative Breast Cancer
Clinical Investigators 47%Regulatory Authorities 35%Industry Developers 18%
4 sources · 72d ago
Research BriefNetwork Medicine
The Evidence Pack: How a Common Nasal Spray Emerged as a Computational Anti-Aging Candidate
Network Medicine Researchers 40%Clinical Pharmacologists 40%Geroscience Advocates 20%
4 sources · 72d ago
ExplainerRespiratory Health
FDA Approves Ohtuvayre, the First COPD Drug with a Novel Mechanism in Over Two Decades
Clinical Researchers 40%Patient Advocates 30%Regulatory & Industry Analysts 30%
4 sources · 72d ago
ExplainerAntibiotic Resistance
FDA Approves Utebzi, the First Oral Carbapenem Antibiotic for Complicated Urinary Tract Infections
Infectious Disease Specialists 41%Antimicrobial Stewardship Advocates 35%Pharmaceutical Developers 24%
3 sources · 72d ago
ExplainerCOVID-19 Prevention
FDA Approves Xocova, the First Oral Antiviral Pill for COVID-19 Post-Exposure Prevention
Infectious Disease Specialists 41%Pharmacologists 35%Public Health Officials 24%
5 sources · 72d ago
ExplainerViral Hepatitis
FDA Approves First-Ever Treatment for Hepatitis Delta Virus, the World's Most Dangerous Form of Viral Hepatitis
Clinical Researchers & Practitioners 44%Regulatory & Public Health Authorities 33%Patient Advocacy Organizations 22%
6 sources · 72d ago
ExplainerSmoking Cessation
FDA Nears Approval of Cytisinicline, the First New Non-Nicotine Smoking Cessation Pill in Two Decades
Addiction Medicine Specialists 40%Public Health Advocates 35%Pharmacological Researchers 25%
6 sources · 72d ago
ExplainerProstate Cancer
Landmark Trial Finds Apalutamide Combo Cuts Metastasis Risk in High-Risk Localized Prostate Cancer
Clinical Oncologists 45%Patient Advocacy Groups 35%Health Economists 20%
7 sources · 73d ago
Deep DivePsychedelic Medicine
FDA Grants Breakthrough Status to Single-Dose LSD Therapy for Generalized Anxiety
Clinical Researchers 40%Regulatory Cautious 35%Patient Advocates 25%
5 sources · 73d ago
Vascular NeurologyMechanism Discovery
Landmark Study Finds Common Stroke Cause is Deep Brain Vessel Damage, Not Arterial Plaque
Neurovascular Researchers 45%Clinical Trial Investigators 35%Patient Advocacy Organizations 20%
4 sources · 66d ago
Research BriefHealthspan Metrics
The Evidence Pack: How Recent US Life Expectancy Gains Are Translating Entirely Into Healthy Years
Biogerontologists 40%Public Health Economists 30%Health Equity Advocates 30%
3 sources · 73d ago
Sleep ApneaExplainer
The Evidence Pack: How a Once-Nightly Pill Targets the Neuromuscular Root Cause of Sleep Apnea
Sleep Medicine Physicians 40%Pharmaceutical Developers 35%Patient Advocates 25%
3 sources · 73d ago
ExplainerFamine Prevention
The Science of Famine Prevention: Decoding the UN's 2026 Global Hunger Hotspots Report
Humanitarian Agencies 45%Nutritional Scientists 30%Geopolitical Analysts 25%
2 sources · 73d ago
ExplainerType 1 Diabetes
The Evidence Pack: How the First Disease-Modifying Therapy Delays Type 1 Diabetes by Nearly Three Years
Clinical Immunologists 40%Pediatric Endocrinologists 35%Public Health Advocates 25%
5 sources · 73d ago